These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 12410780)

  • 21. A randomized trial of buprenorphine maintenance for heroin dependence in a primary care clinic for substance users versus a methadone clinic.
    O'Connor PG; Oliveto AH; Shi JM; Triffleman EG; Carroll KM; Kosten TR; Rounsaville BJ; Pakes JA; Schottenfeld RS
    Am J Med; 1998 Aug; 105(2):100-5. PubMed ID: 9727815
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Quality of life among heroin users on buprenorphine versus methadone maintenance.
    Ponizovsky AM; Grinshpoon A
    Am J Drug Alcohol Abuse; 2007; 33(5):631-42. PubMed ID: 17891656
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A comparison of antagonist-precipitated withdrawal under anesthesia to standard inpatient withdrawal as a precursor to maintenance naltrexone treatment in heroin users: outcomes at 6 and 12 months.
    McGregor C; Ali R; White JM; Thomas P; Gowing L
    Drug Alcohol Depend; 2002 Sep; 68(1):5-14. PubMed ID: 12167548
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A randomised trial of the cost effectiveness of buprenorphine as an alternative to methadone maintenance treatment for heroin dependence in a primary care setting.
    Harris AH; Gospodarevskaya E; Ritter AJ
    Pharmacoeconomics; 2005; 23(1):77-91. PubMed ID: 15693730
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Well-being, psychosocial factors, and side-effects among heroin-dependent inpatients after detoxification using buprenorphine versus clonidine.
    Ponizovsky AM; Grinshpoon A; Margolis A; Cohen R; Rosca P
    Addict Behav; 2006 Nov; 31(11):2002-13. PubMed ID: 16524668
    [TBL] [Abstract][Full Text] [Related]  

  • 26. One year outcomes for heroin dependence: findings from the Australian Treatment Outcome Study (ATOS).
    Teesson M; Ross J; Darke S; Lynskey M; Ali R; Ritter A; Cooke R
    Drug Alcohol Depend; 2006 Jun; 83(2):174-80. PubMed ID: 16343809
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Buprenorphine suppresses heroin use by heroin addicts.
    Mello NK; Mendelson JH
    Science; 1980 Feb; 207(4431):657-9. PubMed ID: 7352279
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A pilot study of naltrexone-accelerated detoxification in opioid dependence.
    Bell JR; Young MR; Masterman SC; Morris A; Mattick RP; Bammer G
    Med J Aust; 1999 Jul; 171(1):26-30. PubMed ID: 10451668
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A controlled comparison of buprenorphine and clonidine for acute detoxification from opioids.
    Cheskin LJ; Fudala PJ; Johnson RE
    Drug Alcohol Depend; 1994 Oct; 36(2):115-21. PubMed ID: 7851278
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tramadol versus buprenorphine for the treatment of opiate withdrawal: a retrospective cohort control study.
    Tamaskar R; Parran TV; Heggi A; Brateanu A; Rabb M; Yu J
    J Addict Dis; 2003; 22(4):5-12. PubMed ID: 14723474
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Buprenorphine/naloxone versus methadone and lofexidine in community stabilisation and detoxification: A randomised controlled trial of low dose short-term opiate-dependent individuals.
    Law FD; Diaper AM; Melichar JK; Coulton S; Nutt DJ; Myles JS
    J Psychopharmacol; 2017 Aug; 31(8):1046-1055. PubMed ID: 28631527
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Short-term outcomes after brief ambulatory opioid detoxification with buprenorphine in young heroin users.
    Gandhi DH; Jaffe JH; McNary S; Kavanagh GJ; Hayes M; Currens M
    Addiction; 2003 Apr; 98(4):453-62. PubMed ID: 12653815
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Buprenorphine versus methadone in the treatment of opioid dependence: self-reports, urinalysis, and addiction severity index.
    Strain EC; Stitzer ML; Liebson IA; Bigelow GE
    J Clin Psychopharmacol; 1996 Feb; 16(1):58-67. PubMed ID: 8834420
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Client and counselor attitudes toward the use of medications for treatment of opioid dependence.
    Rieckmann T; Daley M; Fuller BE; Thomas CP; McCarty D
    J Subst Abuse Treat; 2007 Mar; 32(2):207-15. PubMed ID: 17306729
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacological Management of Heroin Withdrawal Syndrome: A Century of Expert Opinions in Cecil Textbook of Medicine.
    Manu P; Rogozea LM; Shulman M
    Am J Ther; 2022 Feb; 29(2):e193-e198. PubMed ID: 35170499
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacologic treatments for heroin and cocaine dependence.
    Kleber HD
    Am J Addict; 2003; 12(s2):S5-S18. PubMed ID: 12857659
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Preliminary evidence of different and clinically meaningful opioid withdrawal phenotypes.
    Dunn KE; Weerts EM; Huhn AS; Schroeder JR; Tompkins DA; Bigelow GE; Strain EC
    Addict Biol; 2020 Jan; 25(1):e12680. PubMed ID: 30295400
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Heroin-dependent inmates' experiences with buprenorphine or methadone maintenance.
    Awgu E; Magura S; Rosenblum A
    J Psychoactive Drugs; 2010 Sep; 42(3):339-46. PubMed ID: 21053756
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Detoxification in withdrawal state in methadone maintenance patients].
    Sivolap I; Savchenkov VA; Aksel'rod BA; Kubarev DA; Chichenkov TO
    Zh Nevrol Psikhiatr Im S S Korsakova; 2003; 103(11):33-7. PubMed ID: 14681963
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Infants of drug-addicted mothers: pitfalls of replacement therapy].
    Vert P; Hamon I; Hubert C; Legagneur M; Hascoet JM
    Bull Acad Natl Med; 2008 May; 192(5):961-9; discussion 969. PubMed ID: 19238786
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.